{
  "company": {
    "name": "METiS Therapeutics",
    "website": "https://metistx.com/",
    "record": "https://startuphistory.org/c/metistx.com"
  },
  "status": null,
  "history_since": "2021-12-07T18:11:41.000Z",
  "baseline": {
    "snapshot_id": "162eafc666172da67d6e112d37d6fb6ce9a7735fc4ec35c2c2a04ccecdd73bc5",
    "observed_at": "2021-12-07T18:11:41.000Z",
    "headline": "Chris Lai",
    "description": "METiS Pharmaceuticals is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.",
    "evidence": "https://web.archive.org/web/20211207181141/https://www.metistx.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:41:31.438Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2021-12-07T18:11:41.000Z",
      "variants": [
        {
          "headline": "Chris Lai",
          "subhead": "METiS Pharmaceuticals is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.",
          "observed_at": "2021-12-07T18:11:41.000Z",
          "evidence": "https://web.archive.org/web/20211207181141/https://www.metistx.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Chris Lai",
      "subhead": "METiS Pharmaceuticals is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.",
      "from": "2021-12-07T18:11:41.000Z",
      "to": "2021-12-07T18:11:41.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20211207181141/https://www.metistx.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2021-12-07T18:11:41.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:41:31.438Z",
      "variants": [
        {
          "headline": "METiS Therapeutics | AI drug discovery",
          "subhead": "METiS Therapeutics is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.",
          "observed_at": "2022-07-04T15:36:25.000Z",
          "evidence": "https://web.archive.org/web/20220704153625/https://www.metistx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "METiS Therapeutics | AI drug discovery",
          "subhead": "METiS Therapeutics is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.",
          "observed_at": "2023-02-14T09:16:37.000Z",
          "evidence": "https://web.archive.org/web/20230214091637/https://www.metistx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "METiS Therapeutics | AI drug discovery",
          "subhead": "METiS Therapeutics is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.",
          "observed_at": "2023-10-03T20:53:19.000Z",
          "evidence": "https://web.archive.org/web/20231003205319/https://www.metistx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "METiS Therapeutics | AI drug discovery",
          "subhead": "METiS Therapeutics is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.",
          "observed_at": "2024-03-05T04:24:09.000Z",
          "evidence": "https://web.archive.org/web/20240305042409/https://www.metistx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "METiS Therapeutics | AI drug discovery",
          "subhead": "METiS Therapeutics is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.",
          "observed_at": "2025-01-21T05:31:02.000Z",
          "evidence": "https://web.archive.org/web/20250121053102/https://www.metistx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "METiS Therapeutics | AI drug discovery",
          "subhead": "METiS Therapeutics is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.",
          "observed_at": "2025-07-19T15:13:00.000Z",
          "evidence": "https://web.archive.org/web/20250719151300/https://www.metistx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "METiS Therapeutics | AI drug discovery",
          "subhead": "METiS Therapeutics is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.",
          "observed_at": "2026-01-14T23:22:28.000Z",
          "evidence": "https://web.archive.org/web/20260114232228/https://www.metistx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "METiS TechBio",
          "subhead": "METiS TechBio, METiS,Metis TechBio Co., Ltd.",
          "observed_at": "2026-11-06T17:41:31.438Z",
          "evidence": "https://www.metistechbio.com/en/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "METiS TechBio",
      "subhead": "METiS TechBio, METiS,Metis TechBio Co., Ltd.",
      "from": "2022-07-04T15:36:25.000Z",
      "to": "2026-11-06T17:41:31.438Z",
      "captures": 8,
      "evidence": "https://www.metistechbio.com/en/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2022-07-04T15:36:25.000Z",
          "to": "2026-11-06T17:41:31.438Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-60ced983de673a5f95a50ccb1c956eb101dede588767e7f50154e01801977a1e:480eacdc3813bd190e630a9d6a125fc342f695cc866f953273c992235fc577ba:investors:996f56f4ae513056",
      "before_evidence": "https://web.archive.org/web/20220704153625/https://www.metistx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "investors",
      "label": "Investors",
      "summary": "Now shows investor logos: 5Y.png, Lighetspeed.jpg, Free Fund.png, SOURCE CODE CAPITAL.png, CMBI logo_20211129110407 (003).jpeg and XtaIp.png.",
      "between": {
        "from": "2022-07-04T15:36:25.000Z",
        "to": "2023-02-14T09:16:37.000Z"
      },
      "evidence": "https://web.archive.org/web/20230214091637/https://www.metistx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-investor-logos"
    },
    {
      "n": 2,
      "id": "page-60ced983de673a5f95a50ccb1c956eb101dede588767e7f50154e01801977a1e:480eacdc3813bd190e630a9d6a125fc342f695cc866f953273c992235fc577ba:logos:ecc0cc859bdf0216",
      "before_evidence": "https://web.archive.org/web/20220704153625/https://www.metistx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "logos",
      "label": "New logos",
      "summary": "Added logos to its homepage: headshot-Kathy-Rizzo.jpg and headshot-Josh-Kaplan.jpg.",
      "between": {
        "from": "2022-07-04T15:36:25.000Z",
        "to": "2023-02-14T09:16:37.000Z"
      },
      "evidence": "https://web.archive.org/web/20230214091637/https://www.metistx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 3,
      "id": "page-480eacdc3813bd190e630a9d6a125fc342f695cc866f953273c992235fc577ba:dc5f0a0ac520b26954b36a59ea91eb8dae0e5263fef8f52032fb533e6d2dd1a1:logos:8bcdbca4115d30fa",
      "before_evidence": "https://web.archive.org/web/20230214091637/https://www.metistx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "logos",
      "label": "New logos",
      "summary": "Added logos to its homepage: Nassim-Beiranvand.jpg and metis-team_sila-ozdemir.jpg.",
      "between": {
        "from": "2023-02-14T09:16:37.000Z",
        "to": "2023-10-03T20:53:19.000Z"
      },
      "evidence": "https://web.archive.org/web/20231003205319/https://www.metistx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 4,
      "id": "page-1fa92f600893173e994572a6b5a75c3f507d5241c01489b6e768c57c25d4c3e5:67eae1cce7a1bcb1a0fa5034ac7c5e2cbbe705e09bf0607a825bbebbbdc84044:investors:1b053d4b0f5258cf",
      "before_evidence": "https://web.archive.org/web/20240305042409/https://www.metistx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "investors",
      "label": "Investors",
      "summary": "Now shows investor logos: 5y_edited.jpg and L2.png.",
      "between": {
        "from": "2024-03-05T04:24:09.000Z",
        "to": "2025-01-21T05:31:02.000Z"
      },
      "evidence": "https://web.archive.org/web/20250121053102/https://www.metistx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-investor-logos"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “METiS Therapeutics” company record, https://startuphistory.org/c/metistx.com"
}